CROI 2015 Program and Abstracts

Disclosure Information

Landovitz, Raphael Self: Gilead Sciences: Consulting or advisor fee; Gilead Sciences: Provision of medicines, equipment, or administrative support Institution: UCLA: Gilead: Provision of medicines, equipment, or administrative support; Bristol-Myers Squibb: Provision of medicines, equipment, or administrative support; GlaxoSmithKline/ViiV: Provision of medicines, equipment, or administrative support; JanssenTherapeutics: Provision of medicines, equipment, or administrative support Landry, Ishani Savant Self: Bristol-Myers Squibb: Employment; Stock/stock options Institution: Bristol-Myers Squibb: Patents(planned, pending, or issued); Other: Bristol-Myers Squibb is a commercial entity, patenting and developing the drug described within this presentation Larsen, Ellen Self: Gilead: Grants/grants pending Lataillade, Max Self: Bristol-Myers Squibb: Employment; Stock/stock options Institution: Bristol-Myers Squibb: Employment; Stock/stock options; Other Lee, Frederick Self: Calimmune Australia Pty Ltd: Consulting or advisor fee; Janssen Cilag Australia: Grants/grants pending Lee, Samuel Self: Bristol-Myers Squib, Boehringer Ingelheim, Debio, Gilead, Janssen, GlaxoSmithKline, Merck, Novartis, Roche, Vertex: Other; BMS, Gilead, Janssen, Merck, Roche,Vertex.: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus Leroy, Valeraine Self: EDCTP, ANRS, CRP Santé: Grants/grants pending Letendre, Scott Self: AbbVie: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus;ViiV Healthcare: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus; Gilead Sciences: Grants/grants pending; GlaxoSmithKline: Grants/ grants pending; AbbVie: Grants/grants pending Lichtenstein, Kenneth Self: AbbVie Pharmaceuticals: Grants/grants pending Luetkemeyer, Anne Self: Cepheid: Grants/grants pending Institution: UCSF: Cepheid: Grants/grants pending Margolis, David Self: GSK: Employment Marks, Kristen Self: Gilead: Grants/grants pending; Merck: Grants/grants pending; BMS: Grants/grants pending; BI: Grants/grants pending;Vertex: Grants/grants pending Mauss, Stefan Self: Gilead: Consulting or advisor fee; AbbVie: Consulting or advisor fee; Janssen: Consulting or advisor fee; Roche: Consulting or advisor fee; BMS: Consulting or advisor fee Mayer, Kenneth Self: Gilead Sciences: Grants/grants pending

McComsey, Grace Self: Bristol-Myers Squibb, GSK/ViiV, Gilead: Grants/grants pending; Other; Gilead, GSK, Consulting or advisor fee; Merck: Other; Pfizer: Fees for participation in the review activities, eg, data monitoring boards, statistical analysis, or end point adjudication committees McCormack, Sheena Self: Gilead Sciences plc: Grants/grants pending; Gilead Sciences plc: Provision of medicines, equipment, or administrative support Institution: MRC CTU at UCL (Infections Group): Abbott, BMS, Cipla, Gilead,Tibotec, Roche, GSK, Janssen-Cilag, Merck: Provision of medicines, equipment, or administrative support; MRC CTU at UCL (Infections Group): Abbott, BMS, Gilead,Tibotec, Roche, GSK, Janssen-Cilag, Merck: Grants/ grants pending Spouse/partner: BXT Accelyon: Other Mercie, Patrick Self: Gilead: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus; Mercie: B: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus; Mercie: Pfizer: Provision of medicines, equipment, or administrative support Miller, Michael Self: Merck & Co., Inc.: Employment Institution: Merck & Co., Inc.: Merck & Co., Inc: Employment Spouse/partner: Merck & Co., Inc.: Employment Molina, Jean-Michel Self: Gilead: Board Membership; Merck: Board Membership; Janssen: Board Membership;ViiV: Board Membership; Bristol-Myers Squibb: Board Membership Institution: Hopital Saint-Louis: Gilead: Grants/grants pending Monroe, Anne Institution: John Hopkins University: NIH: Grants/grants pending Naggie, Susanna Self: Gilead Sciences, Inc: Consulting or advisor fee; Bristol Meyers Squibb: Consulting or advisor fee; Merck: Consulting or advisor fee; AbbVie: Consulting or advisor fee Institution: Duke University: Gilead: Grants/grants pending; Bristol Meyers Squibb: Grants/grants pending; AbbVie: Grants/grants pending;Vertex: Grants/grants pending; Duke Clinical Research Institute: Gilead: Grants/grants pending; DurhamVA Medical Center: AbbVie: Grants/grants pending Spouse/partner: BTG, International Incorporated: Grants/ grants pending Naqvi, Alissa Self: Gilead Sciences: Board Membership Noy, Ariela Institution: Memorial Sloan Kettering Cancer Center: Pharmacyclics: Other O’Halloran, Jane Self: Janssen Cilag: Other Institution: University College Dublin: Janssen Cilag: Grants/grants pending; GlaxoSmithKline: Grants/grants pending; Gilead Sciences: Grants/grants pending; Bristol- Myers Squibb: Grants/grants pending; Merck: Grants/grants pending; Other: Education grants to facilitate travel to and conference registration

Palella, Frank Self: Janssen Pharmaceuticals, Bristol Myers Squibb, Merck, Gilead Sciences: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus Parkes-Ratanshi, Rosalind Self: Janssen Pharmaceuticals: Consulting or advisor fee Institution: Infectious Diseases Institute: Janssen Pharmaceuticals: Consulting or advisor fee Paton, Nicholas Self: GSK: Grants/grants pending; AbbVie: Other; Janssen: Other; Nicholas Paton has received payment as a speaker for AbbVie and Janssen. Other: the primary presenter has received honoraria for speaking at symposia organized by the two companies listed. Institution: National University of Singapore: GSK: Grants/ grants pending; : GSK: Provision of medicines, equipment, or administrative support Perreau, Matthieu Self: Bristol Myers Squibb: Grants/grants pending Peters, Marion Self: Biotron: Consulting or advisor fee Spouse/partner: Genentech Research and Development: Employment Peytavin, Gilles Self: Bristol-Myers-Squibb, Gilead Sciences, Janssen, Merck andViiV Healthcare: Board Membership; Gilead Sciences, Janssen, Merck andViiV Healthcare: Consulting or advisor fee; Grants/grants pending; Gilead Sciences, Janssen, Merck andViiV Healthcare: Payment for development of education presentations Piroth, Lionel Self: BMS: Consulting or advisor fee; Gilead: Consulting or advisor fee; Pfizer: Consulting or advisor fee;ViiV Healthcare: Consulting or advisor fee Polizzotto, Mark Self: Celgene Corporation: Provision of medicines, equipment, or administrative support Institution: National Cancer Institute: Celgene Corporation: Provision of medicines, equipment, or administrative support ; Other: Research Funding, Celgene Corporation Porter, Danielle Self: Gilead Sciences, Inc.: Employment Quirk, Erin Self: Gilead Sciences: Employment; Gilead Sciences: Stock/ stock options; Other: clinical trial agreements Ramers, Christian Self: Gilead Sciences, AbbVie,ViiV, Janssen: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus Ramgopal, M Institution: Midway Immunology and Research Center: Janssen: Grants/grants pending Raugi, Dana Other: Monogram Biosciences - Research support Rice, Charles Self: Apath, LLC: Other; Merck: Consulting or advisor fee; OnCore: Board Membership; Regeneron: Consulting or advisor fee

Disclosure Information

654

CROI 2015